Literature DB >> 23525395

Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography.

Jian-Wei Wang1, Wei Zheng, Yao Chen, Long-Hui Cao, Rong-Zhen Luo, An-Hua Li, Jian-Hua Zhou.   

Abstract

OBJECTIVES: The purpose of the study was to detect tumor blood flow changes after chemotherapy with contrast-enhanced destruction-replenishment sonography.
METHODS: Twenty-four MCF-7 breast cancer-bearing nude mice were included in this study. Animals received either adriamycin or sterile saline and underwent contrast-enhanced sonography before and after treatment using a destruction-replenishment technique. A monoexponential function, y = A(1 - e(-βt)), was used to fit the replenishment kinetics, where the plateau signal intensity A reflects the percent blood volume; the time constant β reflects the average speed of blood; and their product A*β reflects the nutrient blood flow. Tumor blood perfusion was compared to measurements of cell density and microvascular density.
RESULTS: Volumes of the treated tumors were significantly reduced after 7 days of adriamycin treatment compared with the control tumors (P < .001). Before adriamycin administration, there was no significant difference in blood perfusion between the treated and control groups (P > .05). Treatment with adriamycin resulted in a significant decrease in A, β, and A*β (P <.001) compared with the control tumors. The tumor cell density and microvascular density estimated by pathologic slices were significantly lower in the treated tumors than in the control tumors (P <.001).
CONCLUSIONS: Quantification of tumor blood flow using contrast-enhanced destruction-replenishment sonography shows the potential to evaluate tumor responses to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525395     DOI: 10.7863/jum.2013.32.4.683

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

1.  Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.

Authors:  Huaijun Wang; Amelie M Lutz; Dimitre Hristov; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2016-08-04       Impact factor: 11.105

2.  Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.

Authors:  Huaijun Wang; Dimitre Hristov; Jiale Qin; Lu Tian; Jürgen K Willmann
Journal:  Radiology       Date:  2015-05-22       Impact factor: 11.105

3.  Clinical value of contrast-enhanced ultrasound in improving diagnostic accuracy rate of transthoracic biopsy of anterior-medial mediastinal lesions.

Authors:  Jingjing Fu; Wei Yang; Song Wang; Jing Bai; Hao Wu; Haiyue Wang; Kun Yan; Minhua Chen
Journal:  Chin J Cancer Res       Date:  2016-12       Impact factor: 5.087

Review 4.  Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow.

Authors:  Robert J Gillies; Joel S Brown; Alexander R A Anderson; Robert A Gatenby
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

5.  Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.

Authors:  Yao Chen; Feng Han; Long-Hui Cao; Cheng Li; Jian-Wei Wang; Qing Li; Wei Zheng; Zhi-Xing Guo; An-Hua Li; Jian-Hua Zhou
Journal:  BMC Cancer       Date:  2015-03-17       Impact factor: 4.430

6.  Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy.

Authors:  Ryu Kanzaki; Hisamichi Naito; Kazuyoshi Kise; Kazuhiro Takara; Daisuke Eino; Masato Minami; Yasushi Shintani; Soichiro Funaki; Tomohiro Kawamura; Toru Kimura; Meinoshin Okumura; Nobuyuki Takakura
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.